Find Grants for Higher Education

Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.

$ 100 Trillion
Total Dollars Available

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Deadline: February 8, 2027


Opportunity Number: RFA-MH-26-170

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: February 8, 2027

Status: Posted

CFDA Numbers: 93.273, 93.213, 93.866, 93.867, 93.242, 93.286, 93.853, 93.865, 93.173, 93.279

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Deadline: November 5, 2026


Opportunity Number: PAR-25-255

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: November 5, 2026

Status: Posted

CFDA Numbers: 93.399, 93.242, 93.172

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027


Opportunity Number: PAR-25-256

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.172

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-273

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.351

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Deadline: May 4, 2028


Opportunity Number: PA-25-168

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: May 4, 2028

Status: Posted

CFDA Numbers: 93.273, 93.865, 93.279, 93.172, 93.313, 93.351, 93.867, 93.310, 93.846, 93.838, 93.847, 93.113, 93.853, 93.397, 93.855, 93.213, 93.361, 93.286, 93.233, 93.242, 93.840, 93.399, 93.398, 93.837, 93.173, 93.121, 93.839, 93.866, 93.396, 93.859

Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)

Deadline: March 5, 2026


Opportunity Number: PAR-25-209

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: March 5, 2026

Status: Posted

CFDA Numbers: 93.866

Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)

Deadline: April 20, 2027


Opportunity Number: RFA-ES-25-002

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: April 20, 2027

Status: Posted

CFDA Numbers: 93.113

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-203

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.859

Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-202

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.859

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)

Deadline: June 22, 2026


Opportunity Number: PAR-25-170

Agency: National Institutes of Health

Open Date: November 13, 2024

Close Date: June 22, 2026

Status: Posted

CFDA Numbers: 93.399, 93.853, 93.866

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-167

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.393

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Deadline: September 7, 2028


Opportunity Number: PA-25-253

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: September 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-027

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.121

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Deadline: January 7, 2027


Opportunity Number: PAR-25-081

Agency: National Institutes of Health

Open Date: November 12, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393, 93.399, 93.394, 93.395

Laboratories to Optimize Digital Health (R01 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PAR-25-136

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PA-25-172

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393

NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)

Deadline: March 6, 2026


Opportunity Number: PAR-25-049

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: March 6, 2026

Status: Posted

CFDA Numbers: 93.853

NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-234

Agency: National Institutes of Health

Open Date: November 7, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.853

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-079

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.395, 93.394

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-063

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.242

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-153

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.395

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Deadline: September 7, 2027


Opportunity Number: PAR-24-325

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.866, 93.867, 93.286, 93.395, 93.394

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-145

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

Deadline: May 7, 2026


Opportunity Number: PAR-25-036

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.866, 93.242

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-175

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393, 93.395, 93.394

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.